These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2778319)

  • 21. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
    Rock KL; Rothstein L; Gamble S; Fleischacker C
    J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them.
    Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA
    J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
    Fischer HG; Frosch S; Reske K; Reske-Kunz AB
    J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells.
    Ullrich SE
    J Immunol; 1994 Apr; 152(7):3410-6. PubMed ID: 8144924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania major interferes with antigen presentation by infected macrophages.
    Fruth U; Solioz N; Louis JA
    J Immunol; 1993 Mar; 150(5):1857-64. PubMed ID: 8436821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophages, but not dendritic cells, present collagen to T cells.
    Michaëlsson E; Holmdahl M; Engström A; Burkhardt H; Scheynius A; Holmdahl R
    Eur J Immunol; 1995 Aug; 25(8):2234-41. PubMed ID: 7545114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular interference with antigen presentation.
    Leyva-Cobian F; Unanue ER
    J Immunol; 1988 Sep; 141(5):1445-50. PubMed ID: 3137257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The affection of antigen presentation ability, which sources from the spleen macrophage of Balb/c mouse during late gestation, on maternal Th2/Th1 type of immune].
    Tan ZJ; Li SW; Cao ZY; Li L; Huang ZY; Ma QH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):839-42. PubMed ID: 17953373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of macrophage hybridomas. I. Production and initial characterization.
    Uchida T; Ju S; Fay A; Liu Y; Dorf ME
    J Immunol; 1985 Feb; 134(2):772-8. PubMed ID: 3155541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Processing and presentation of ovalbumin in mice genetically selected for antibody response.
    Vidard L; Rock KL; Couderc J; Mouton D; Benacerral B
    Eur J Immunol; 1992 Aug; 22(8):2165-8. PubMed ID: 1379188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation requirements of cloned inducer T cells. II. The failure of some clones to respond to antigen presented by activated B cells.
    Dekruyff RH; Cantor H; Dorf ME
    J Immunol; 1986 Jan; 136(2):446-51. PubMed ID: 3484492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
    Stout RD; Bottomly K
    J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the mechanisms of defective antigen presentation after hemorrhage.
    Ertel W; Morrison MH; Ayala A; Chaudry IH
    Surgery; 1991 Aug; 110(2):440-5; discussion 445-7. PubMed ID: 1858052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal c-myc transformed macrophage cell lines. I. Heterogeneity in ability to process and present antigen.
    Trannoy E; Manser T; Cole MD; Daley MJ
    J Immunol; 1993 Sep; 151(6):3042-56. PubMed ID: 8104218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine macrophage cell line AP284 presents antigen to cloned MT4+, Lyt-2- T cells in vitro and in vivo.
    Klasen IS; de Jong JP; Voerman JS; Ladestein RM; Leenen PJ; Benner R
    Immunobiology; 1988 Dec; 178(3):261-74. PubMed ID: 2906628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors.
    Dal Monte P; Szoka FC
    J Immunol; 1989 Mar; 142(5):1437-43. PubMed ID: 2465339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
    Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
    Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.